Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determination of Target of Adequate Partial Neuromuscular Blockade for Electrophysiologic Monitoring During Microvascular Decompression Surgery

NCT01598961 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT01598961
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01598961 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determination of Target of Adequate Partial Neuromuscular Blockade for Electrophysiologic Monitoring During Microvascular Decompression Surgery
Lead sponsor
Samsung Medical Center
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2012
Completion date
April 30, 2013
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemifacial spasm, lateral spread response monitoring, microvascular decompression